Compare ATRC & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | ULCC |
|---|---|---|
| Founded | 2000 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2005 | 2017 |
| Metric | ATRC | ULCC |
|---|---|---|
| Price | $28.80 | $4.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 8 |
| Target Price | ★ $51.17 | $5.21 |
| AVG Volume (30 Days) | 706.1K | ★ 6.3M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $201,630,000.00 | ★ $3,724,000,000.00 |
| Revenue This Year | $15.27 | $23.76 |
| Revenue Next Year | $12.21 | $11.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $26.62 | $3.02 |
| 52 Week High | $43.18 | $6.66 |
| Indicator | ATRC | ULCC |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 53.56 |
| Support Level | $28.03 | $4.01 |
| Resistance Level | $30.75 | $4.15 |
| Average True Range (ATR) | 1.36 | 0.35 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 54.98 | 39.44 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.